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Several α-alkylated β-amino esters have been obtained via 
DKR processes employing a kit of transaminases and isopro-
pylamine as amino donor in aqueous medium at mild condi-
tions. Thus, while acyclic α-alkyl-β-keto esters afforded ex-
cellent conversions and enantioselectivities, although usually 10 
low diastereoselectivities, with more constrained cyclic β-keto 
esters high to excellent inductions were obtained. 
The development of enzymatic strategies that enable access to 
100% theoretical yield of stereoisomerically enriched compounds 
starting from easily available racemic or prochiral derivatives, 15 
has recently attracted many efforts due to the simpler isolation 
and purification techniques required.1 In this sense, recent ad-
vances achieved in dynamic systems to get access to enantio- or 
diastereomerically pure compounds have been described. Thus, 
performing a kinetic resolution on a substrate which simulta-20 
neously can undergo racemization has led to efficient dynamic 
kinetic resolutions (DKRs).2 While this methodology has exten-
sively been employed with hydrolases (usually in combination 
with a metal-based racemization)3 and oxidoreductases (often 
combined with a racemization in basic conditions),4 for other 25 
enzymes it has been scarcely exploited. 
 For instance, with ω-transaminases (ω-TAs, EC 2.6.1.x),5 one 
of the most promising biocatalysts applied to the synthesis of 
chiral amines, it is remarkable that only one example described 
by Kroutil and co-workers can be recognized as a dynamic ki-30 
netic resolution.6 In this contribution, the authors proposed the 
DKR of an α-chiral aldehyde through spontaneous racemization 
combined with the use of an ω-TA to afford, after ring closure, 4-
phenylpyrrolidin-2-one with 92% isolated yield and 68% ee. 
 35 
Scheme 1 General overview for the synthesis of enantioenriched α-
alkylated β-amino esters through ω-TA-catalyzed dynamic amination. 
 Due to our previous experience with the synthesis of several α-
alkylated β-keto esters,4a,d and since these substrates can racemize 
at neutral pH, it was decided to study the DKR of these com-40 
pounds through ω-TA-catalyzed amination to obtain the co-
rresponding α-substituted β-amino esters (Scheme 1). These 
compounds have a great relevance since they are present in bio-
logically active peptides,7 and are also valuable for the prepara-
tion of peptidomimetics,8 substituted β-lactams9 and β-amino 45 
acids.10 The selective synthesis of these unprotected synthons is 
challenging,11 and no general strategy comprising the direct 
asymmetric reductive amination of the α-substituted β-keto ester 
precursors has been described until now.12 
 50 
Scheme 2 Synthesis of racemic aliphatic α-substituted β-amino ester 
derivatives through enamine formation-reduction protocol. 
 Thus, it was planned the synthesis of racemic β-keto esters 1b-
k and the corresponding mixture of syn and anti diastereoisomers 
of the α-substituted β-amino esters 2b-k and 3b-k (Scheme 2), to 55 
optimize the analytical methods to measure the enzymatic con-
versions and the enantio- and diastereoselectivities. Compounds 
1b-k were achieved through treatment of the β-keto ester precur-
sors with the corresponding alkyl halide in basic medium.4a,d In a 
subsequent step, adapting a protocol described by Brandt and co-60 
workers,13 ultrasonication of these derivatives under the presence 
of benzylamine at 30 ºC smoothly afforded the (Z)-N-benzylated 
enamine esters 4b-k in excellent yields. Then, the corresponding 
N-protected β-amino esters syn-5b-k and anti-6b-k were obtained 
as diastereoisomeric mixtures by reduction of the C=C double 65 
bond with NaBH(OAc)3 at 0 ºC in high yields. As previously 
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described, the syn isomers were preferentially formed.11d,14 In a 
last step, deprotection of these compounds under hydrogenation 
conditions afforded the racemic α-substituted β-amino esters syn-
2b-k and anti-3b-k in high yields. A series of alkyl derivatives 
were synthesized changing the α-alkyl chain (R2= Me, Et, Bn) 5 
and the ester alkyl moiety (R3= Me, Et, iPr). Furthermore, cyclic 
compounds 1j and 1k, were also tried as substrates to study the 
effect of constrained systems in these dynamic processes. 
 To perform these biocatalyzed transformations, a series of 24 
commercially available transaminases, Codex® Transaminase 10 
Screening Kit, was tried as most of them are able to work under 
the very convenient conditions using isopropylamine in molar 
excess as amino donor.15 In a first set of experiments, unsubsti-
tuted ethyl acetoacetate 1a was studied as substrate for these TAs 
(Tables S2-S3 in ESI) using alanine or isopropylamine as amino 15 
donors. Better conversions were achieved in the second case 
utilizing an excess (1 M) of the amine in phosphate buffer 100 
mM pH 7.5, and in the presence of PLP (1 mM) and DMSO (2.5% 
v v-1) for solubility reasons. Various (S)- and (R)-selective en-
zymes were detected showing very high to excellent conversions 20 
and stereoselectivities. Especially the last ones are interesting 
since not many (R)-selective TAs are described in the literature.16 
 Then, different reaction conditions were explored to optimize 
the transamination process using α-ethylated keto ester 1c as 
substrate. After enzymatic screening, a few TAs were chosen as 25 
suitable catalysts since they afforded a diastereomeric mixture of 
2c and 3c with high conversions, excellent ee and moderate to 
high de. Some parameters such as pH, temperature, biocatalyst 
loading and addition of basic resins were studied to improve the 
DKR conditions (see Tables S4-S5 in ESI), but no positive effect 30 
was observed. Therefore, 30 ºC and pH 7.5 were selected as the 
best conditions to perform these transformations. 
 As a further step, the TA-catalyzed reactions with α-alkylated 
β-keto esters 1b-i were attempted to have an overview of the 
effect that could present: a) the alkyl group at α-position, and b) 35 
the substitution in the ester moiety. The results are shown in 
Table 1 and Tables S6-S13 in ESI. In all cases it was found that 
12 TAs showed (S)-stereopreference while other 12 were (R)-
selective. It was remarkable that with just few exceptions (ATA-
007, ATA-009, and ATA-117), these biocatalysts afforded high 40 
conversions for these substrates and were highly specific for the 
amination of the carbonyl group, showing excellent selectivities 
at position 3, just obtaining in most cases 2 out of 4 diastereoiso-
mers. 
 Regarding the (S)-selective family of transaminases, generally 45 
the syn-(2R,3S) isomers were provided in slight excess (up to 
60/40) and very high conversions (around 90%). Among them, 
ATA-224, ATA-234, TA-P1-F12, and TA-P1-G05 were the most 
active. (S)-selective enzymes TA-P1-A06, TA-P1-G06 and ATA-
103 afforded preferentially anti-(2S,3S)-3b, 3c, 3f, and 3i with 50 
moderate to high diastereomeric ratios.  (R)-Selective biocatalysts 
also showed a slight stereopreference for the formation of the 
enantiopure syn-(2S,3R) amino esters (usually up to 60/40) with 
excellent conversions (>90%), especially ATA-015, ATA-016, 
ATA-024, ATA-025, and ATA-033. Although showing lower 55 
conversions, TA-P2-A07 was the most selective enzyme for most 
of the keto esters. In contrast, ATA-301 presented an opposite 
diastereopreference for anti-(2R,3R), in some cases higher than 
80/20. For some TAs, e.g. TA-P1-A06 and ATA-301, it remained 
clear that the presence of a benzyl moiety at α-position could 60 
largely influence the diastereoselectivity of the process (Figures 
S1 and S2 in ESI). 
 Next, it was envisaged that the employment of more 
constrained derivatives could improve the diastereoselectivity of 
the process while maintaining the excellent ee. Therefore, two 65 
cyclic compounds (1j and 1k) were tried as possible amino 
acceptors for these TAs (Tables S14-S15 in ESI). 
Table 1. Selected results from the transamination of racemic acyclic α-alkyl-β-keto esters 1b-i using isopropylamine as amino donor (t= 24 h).a 
  (S)-Selective (R)-Selective 
Entry 1b-i Enzyme c (%)b Ratio 2/3 ee 2 (%)c ee 3 (%)c Enzyme c (%)b Ratio 2/3 ee 2 (%)c ee 3 (%)c 
1 1b TA-P1-A06 88 34/66 >99 (2R,3S) >99 (2S,3S) ATA-301 25 17/83 n.d. >99 (2R,3R) 
2  ATA-113 89 57/43 >99 (2R,3S) >99 (2S,3S) TA-P2-A07 61 58/42 >99 (2S,3R) >99 (2R,3R) 
3 1c TA-P1-A06 87 16/84 >99 (2R,3S) >99 (2S,3S) ATA-301 21 20/80 n.d. 98 (2R,3R) 
4  ATA-231 88 54/46 >99 (2R,3S) >99 (2S,3S) TA-P2-A07 47 62/38 >99 (2S,3R) >99 (2R,3R) 
5 1d TA-P1-A06 98 58/42 >99 (2R,3S) >99 (2S,3S) ATA-024 >99 56/44 >99 (2S,3R) >99 (2R,3R) 
6 1e -- -- -- -- -- ATA-301 39 36/64 >99 (2S,3R) >99 (2R,3R) 
7  TA-P1-G05 88 56/44 >99 (2R,3S) >99 (2S,3S) TA-P2-A07 79 55/45 >99 (2S,3R) >99 (2R,3R) 
8 1f TA-P1-A06 93 29/71 >99 (2R,3S) >99 (2S,3S) ATA-301 41 32/68 >99 (2S,3R) >99 (2R,3R) 
9  ATA-224 93 55/45 >99 (2R,3S) >99 (2S,3S) TA-P2-A07 50 58/42 >99 (2S,3R) >99 (2R,3R) 
10 1g -- -- -- -- -- ATA-301 47 32/68 >99 (2S,3R) >99 (2R,3R) 
11  TA-P1-G05 94 57/43 >99 (2R,3S) >99 (2S,3S) ATA-025 95 54/46 >99 (2S,3R) >99 (2R,3R) 
12 1h -- -- -- -- -- ATA-301 35 38/62 >99 (2S,3R) >99 (2R,3R) 
13  ATA-103 88 54/46 >99 (2R,3S) >99 (2S,3S) TA-P2-A07 53 54/46 >99 (2S,3R) >99 (2R,3R) 
14 1i ATA-103 94 23/77 >99 (2R,3S) >99 (2S,3S) -- -- -- -- -- 
15  TA-P1-F12 98 58/42 >99 (2R,3S) >99 (2S,3S) ATA-301 89 59/41 >99 (2S,3R) >99 (2R,3R) 
a For other enzymatic results and experimental conditions, see ESI. b Measured by GC. c Measured by chiral GC. 
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 For 1j generally lower conversions (<40%) were observed, but 
several (S)-selective biocatalysts could afford preferentially the 
anti-(2R,1’S) isomer, while (R)-TAs did not show good selectivi-
ties. Better results were obtained for keto ester 1k, finding that 
ATA-113 and TA-P1-G05 were able to produce anti-(1S,2S)-3k 5 
with very high conversions, ee (>99%) and de (94-96%). Thus, a 
50 mg-scale reaction was achieved with TA-P1-G05 obtaining by 
simple acid-base extraction the chiral amino ester (1S,2S)-3k with 
a good yield and excellent ee and de (Scheme 3).17 
 10 
Scheme 3 Synthesis of (1S,2S)-3k through a DKR process with a 
transaminase using isopropylamine as amino donor. 
 Herein we show our first results about the application of a set 
of commercially available ω-TAs to provide several α-alkylated 
β-amino esters using a dynamic protocol. These highly interesting 15 
targets are difficult to synthesize by other methodologies and in 
most cases the synthetic routes involve several steps or the em-
ployment of harsh conditions. Thus, a series of acyclic α-alkyl-β-
keto esters were synthesized and used as substrates for these 
enzymes, finding that although excellent conversions and ee were 20 
achieved for many of them, diastereoselectivities remained mo-
dest with few exceptions. As an additional extension, the appli-
cation of two constrained cyclic derivatives was performed to 
study their effect in the transamination reactions. Gratifyingly, 
racemic ethyl 2-oxocyclopentanecarboxylate showed excellent ee 25 
and de under our dynamic conditions, so the corresponding amino 
ester anti-(1S,2S)-3k could be synthesized at higher scale. With 
these preliminary results in hand, the application of these bioca-
talysts over new constrained substrates will be done, and due to 
the development of highly efficient tools in the Molecular Bio-30 
logy field,16b,18 the design of novel transaminases that could 
provide specifically each diastereoisomer in enantiomerically 
pure form seems highly feasible in a near future. 
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